Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

5.02
Delayed Data
As of Jun 30
 -0.18 / -3.46%
Today’s Change
3.60
Today|||52-Week Range
12.60
-16.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues69.0K1.1M1.7M1.9M
 
 
 
 
 
Depreciation And Amortization60.0K70.0K174.0K210.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses15.1M19.0M24.0M17.9M
 
 
 
 
 
Research And Development6.6M11.3M18.1M12.2M
 
 
 
 
 
Total Operating Expenses15.2M19.1M24.2M18.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.1M-18.0M-22.4M-16.2M
 
 
 
 
 
Extraordinary Credit28.0K570.0K--0.00
 
 
 
Extraordinary Charge0.000.00-322.0K-51.0K
 
 
 
Other Expenses-54.0K5.5M104.0K-274.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.1M-11.9M-22.6M-16.5M
 
 
 
 
 
Income Taxes-1.4M-1.7M-3.2M-2.1M
 
 
 
 
 
Preferred Dividend-728.0K-9.3M-200.0K-201.0K
 
 
 
 
 
Discontinued Operations570.0K57.0K19.0K0.00
 
 
 
 
Net Income-13.2M-10.2M-19.4M-14.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS691.0K1.3M1.8M2.7M
 
 
 
 
 
Shares To Calculate EPS Diluted691.0K1.3M1.8M2.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$20.16-$15.36-$10.68-$5.40
 
 
 
 
 
EPS Diluted-$20.16-$15.36-$10.68-$5.40